Skip to main content
SpringerLink
Log in

Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Background

The introduction of more sensitive techniques, such as Luminex® for HLA antibody screening of patients awaiting organ transplantation has resulted in a better understanding of transplantation immunology and improvements in clinical practice.

Objective

The interpretation of the results obtained only by Luminex® can lead to inaccurate evaluation of a patient’s antibody status and unjustified rejection of a potential organ donor. The aim of this study was to demonstrate the benefits of performing HLA antibody screening in the sera of patients on the waiting list for organ transplantation by two different assays, complement dependent cytotoxicity (CDC) and Luminex®.

Methods

A retrospective analysis was performed on 563 pretransplant serum samples from 141 patients on the kidney transplantation waiting list in Rijeka, tested from March 2012 until March 2015. All samples were tested in parallel by the CDC assay and the Luminex®-based assay.

Results

Out of the 563 samples tested 302 (53.7%) tested negative for HLA antibodies and 88 (15.6%) positive by both assays. From 173 (30.7%) samples with discordant results 149 (26.5%) were CDC negative and Luminex® positive, while 24 (4.3%) were CDC positive and Luminex® negative. Among the Luminex positive patients seven did not experience any immunizing events.

Conclusion

Evaluation of the HLA antibody status in patients on a waiting list for organ transplantation should be based on the results of the both CDC and Luminex® (or other sensitive) assays in accordance to information about patient’s clinical status and exposure to immunizing events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lobashevsky AL. Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation. World J Transplant. 2014;4(3):153–67.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Terasaki PI, Kreisler M, Mickey RM. Presensitization and kidney transplant failures. Postgrad Med J. 1971;47:89–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Terasaki PI, Cai J. Humoral theory of transplantation: further evidence. Curr Opin Immunol. 2005;17:541–5.

    Article  CAS  PubMed  Google Scholar 

  4. Vlad G, Ho EK, Vasilescu ER, et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol. 2009;70(8):589–94.

    Article  CAS  PubMed  Google Scholar 

  5. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation. 2002;74(10):1377–81.

    Article  PubMed  Google Scholar 

  6. Süsal C, Opelz G. Impact of HLA matching and HLA antibodies in organ transplantation. A collaborative transplant study view. Methods Mol Biol. 2012;88:267–77.

    Article  Google Scholar 

  7. Jawdeh ABG, Cuffy MC, Alloway RR, Shields AR, Woodle ES. Desensitization in kidney transplantation: review and future perspectives. Clin Transplant. 2014;28(4):494–507.

    Article  PubMed  Google Scholar 

  8. Paramesh AS, Zhang R, Baber J, et al. The effect of HLA mismatch on highly sensitized renal allograft recepients. Clin Transplant. 2010;24(6):E247–E252.

    Article  PubMed  Google Scholar 

  9. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature. 1964;204:998–1000.

    Article  CAS  PubMed  Google Scholar 

  10. Gebel HM, Bray RA, Nicherson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant. 2003;3:1488–500.

    Article  PubMed  Google Scholar 

  11. Patel R, Terasaki PI. Significance of the positive cross-match test in kidney transplantation. N Engl J Med. 1969;280:735–9.

    Article  CAS  PubMed  Google Scholar 

  12. Morales-Buenrostro LE, Terasaki PI, Marino-Vázquez LA, et al. “Natural” human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation. 2008;86(8):1111–5.

    Article  CAS  PubMed  Google Scholar 

  13. Süsal C, Ovens J, Mahmoud K, et al. No association of kidney graft loss with human leucocyte antigen antibodies detected exclusively by sensitive luminex-single antigen testing: a collaborative transplant study report. Transplantation. 2011;91(8):883–7.

    Article  PubMed  Google Scholar 

  14. Grubić Z, Žunec R, Čečuk-Jelić E, Kerhin-Brkljačić V, et al. Polymorphism of HLA-A,-B,-DRB1,-DQA1 and -DQB1 haplotypes in Croatian population. Eur J Immunogenet. 2000;27(1):47–51.

    Article  PubMed  Google Scholar 

  15. Mehra KN. The role of HLA matching and recipient sensitization in organ allograft outcom. In: Tait BD, editor. The HLA complex in biology and medicine: A resource book, 1st edn. Chapter 29. New Delhi: Jaypee Brothers Medical Publisher; 2010. pp. 491–509.

    Google Scholar 

  16. Gombos P, Opelz G, Scherer S, Morath C, Zeier M, Schemmer P, Süsal C. Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant. 2013;13(8):2075–82.

    Article  CAS  PubMed  Google Scholar 

  17. Sumitran-Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant. 2001;16:897–904.

    Article  CAS  PubMed  Google Scholar 

  18. Süsal C, Dohler B, Sadeghi M, Ovens J, Opelz G. HLA antibodies and occurrence of early adverse events inthe modern era of transplantation: a collaborative transplant study report. Transplantation. 2009;87:1367–71.

    Article  PubMed  Google Scholar 

  19. Everly MJ. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients. Clin Transpl. 2011;(2011):333–6.

    Google Scholar 

  20. Tait BD, Süsal C, Gebel HM, Nickerson PW, et al. Consesus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95:19–47.

    Article  CAS  PubMed  Google Scholar 

  21. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leucocyte antigen flow cytometry beads for accurate identification of human leucocyte antigen antibody specificities. Transplantation. 2003;75:43–9.

    Article  CAS  PubMed  Google Scholar 

  22. Colombo MB, Haworth SE, Poli F, et al. Luminex technology for anti-HLA antibody screening: evaluation on performance and of impact on laboratory routine. Cytometry B Clin Cytom. 2007;72((6):465–71.

    Article  PubMed  Google Scholar 

  23. Tait BD, Hudson F, Cantwell L, Brewin G, et al. Review article: luminex technology for HLA antibody detection in organ transplantation. Nephrology (Carlton). 2009;14:247–54.

    Article  CAS  Google Scholar 

  24. Pereira S, Perkins S, Lee JH, et al. Donor-specific antibody against denatured HLA-A1: non clinically significant? Human Immunol. 2011;72:492–8.

    Article  CAS  Google Scholar 

  25. Tait BD, Hudson F, Brewin G, Cantwell L, et al. Solid phase HLA antibody detection technology – Challenges in interpretation. Tissue Antigens. 2010;76:87–95.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank all staff members of our HLA laboratory for great technical assistance.

Author information

Authors and Affiliations

  1. Tissue Typing Laboratory, Clinical Institute for Transfusion Medicine, Clinical Hospital Center Rijeka, Tome Strižića 3, 51 000, Rijeka, Croatia

    Nataša Katalinić, Marina Fućak, Tajana Crnić, Milena Ćurković, Alma Starčević & Sanja Balen

  2. Faculty of Medicine, University of Rijeka, Rijeka, Croatia

    Sanja Balen

Authors
  1. Nataša Katalinić
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina Fućak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tajana Crnić
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Milena Ćurković
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alma Starčević
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sanja Balen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nataša Katalinić.

Ethics declarations

Conflict of interest

N. Katalinić, M. Fućak, T. Crnić, M. Ćurković, A. Starčević and S. Balen declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katalinić, N., Fućak, M., Crnić, T. et al. Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays. Wien Klin Wochenschr 129, 33–37 (2017). https://doi.org/10.1007/s00508-016-1094-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-016-1094-6

Keywords

Search

Navigation